Advertisement

Pediatric Cardiology

, Volume 34, Issue 1, pp 88–94 | Cite as

Comparison of the Efficacy of Different-Sized Amplatzer Duct Occluders (I, II, and II AS) in Children Weighing Less Than 10 kg

  • Osman BaspinarEmail author
  • Ahmet Irdem
  • Ercan Sivasli
  • Derya Aydin Sahin
  • Metin Kilinc
Original Article

Abstract

The transcatheter closure of patent ductus arteriosus (PDA) may cause more complications in small children. Amplatzer (St. Jude Medical, Plymouth, MN) has produces three types of devices for ductal occlusion: the Amplatzer duct occluder I (ADO I) and II (ADO II) and the recently introduced ADO II additional sizes (ADO II AS). We performed this study to determine the efficacy and complication rates in children who weigh <10 kg for the three types of devices used in our clinic. Between February 2007 and March 2012, 77 patients weighing <10 kg had their PDAs occluded with ADOs. The mean age of the patients was 0.76 ± 0.44 years (range 17 days–2 years), and their mean weight was 6.73 ± 2.05 (range 1.2–9.9) kg. In total, 54 girls (70.1 %) and 23 boys (29.9 %) with a mean pulmonary ductus diameter of 2.55 ± 1.0 (1.08–5.94) mm were included in the study. The ADO I was used in 26 patients (33.8 %); the ADO II was used in 43 patients (55.8 %); and the ADO II AS was used in 8 patients (10.4 %). The mean ages of patients with the ADO I, ADO II, and ADO II AS were 1.07 ± 0.48, 0.66 ± 0.31, and 0.28 ± 0.17 years (p < 0.05), respectively. Their mean weights were 7.86 ± 1.45, 6.50 ± 1.85, and 4.36 ± 2.49 kg (p < 0.05), respectively. Their mean narrowest ductal diameters were 3.11 ± 0.96, 2.25 ± 1.06, and 2.33 ± 1.01 mm (p < 0.05), respectively. The use of the ADO II and ADO II AS was found to be more common in type C defects. One patient with the ADO I and 5 patients with the ADO II (7.8 %) developed varying degrees of left pulmonary artery stenosis or iatrogenic aortic coarctation. In 1 patient, the ADO II AS was replaced with the ADO II due to a significant residual shunt observed during the procedure. Each of the ADOs has its own advantages and disadvantages. Although the ADO I is convenient for medium- and large-sized defects, the ADO II and ADO II AS can be used both anterogradely and retrogradely. The ADO II AS is safe and efficient to use in small infants.

Keywords

Amplatzer duct occluders Small infants Patent ductus arteriosus Transcatheter closure 

Notes

Conflict of interest

None to report.

References

  1. 1.
    Bass JL, Wilson N (2011) Transcatheter occlusion of the patent ductus arteriorus in infants—experimental testing of a new Amplatzer device. Catheter Cardiovasc Interv. doi: 10.1002/ccd.22931 Google Scholar
  2. 2.
    Bentham J, Meur S, Hudsmith L, Archer N, Wilson N (2011) Echocardiographically guided catheter closure of arterial ducts in small preterm infants on the neonatal intensive care unit. Catheter Cardiovasc Interv 77:409–415PubMedCrossRefGoogle Scholar
  3. 3.
    Bhole V, Miller P, Mehta C, Stumper O, Reinhardt Z, De Giovanni JV (2009) Clinical evaluation of the new Amplatzer duct occluder II for patent arterial duct occlusion. Catheter Cardiovasc Interv 74:762–769PubMedCrossRefGoogle Scholar
  4. 4.
    Brunetti MA, Ringel R, Owada C, Coulson J, Jennings JM, Hoyer MH et al (2010) Percutaneous closure of patent ductus arteriosus: a multi-institutional registry comparing multiple devices. Catheter Cardiovasc Interv 76:696–702PubMedCrossRefGoogle Scholar
  5. 5.
    Butera G, De Rosa G, Chessa M, Piazza L, Delogu A, Frigiola A et al (2004) Transcatheter closure of persistent ductus arteriosus with the Amplatzer duct occluder in very young symptomatic children. Heart 90:1467–1470PubMedCrossRefGoogle Scholar
  6. 6.
    Celiker A, Aypar E, Karagoz T, Dilber E, Ceviz N (2005) Transcatheter closure of patent ductus arteriosus with Nit-Occlud coils. Catheter Cardiovasc Interv 65:569–576PubMedCrossRefGoogle Scholar
  7. 7.
    Dimas VV, Takao C, Ing FF, Mattamal R, Nugent AW, Grifka RG et al (2010) Outcomes of transcatheter occlusion of patent ductus arteriosus in infants weighing ≤6 kg. JACC Cardiovasc Interv 3:1295–1299PubMedCrossRefGoogle Scholar
  8. 8.
    Dua J, Chessa M, Piazza L, Negura D, Micheletti A, Bussadori C et al (2009) Initial experience with the new Amplatzer duct occluder II. J Invasive Cardiol 21:401–405PubMedGoogle Scholar
  9. 9.
    Faella HJ, Hijazi ZM (2000) Closure of the patent ductus arteriosus with the Amplatzer PDA device: immediate results of the international clinical trial. Catheter Cardiovasc Interv 51:50–54PubMedCrossRefGoogle Scholar
  10. 10.
    Forsey J, Kenny D, Morgan G, Hayes A, Turner M, Tometzki A et al (2009) Early clinical experience with the new Amplatzer duct occluder II for closure of the persistent arterial duct. Catheter Cardiovasc Interv 74:615–623PubMedCrossRefGoogle Scholar
  11. 11.
    Francis E, Singhi AK, Lakshmivenkateshaiah S, Kumar RK (2010) Transcatheter occlusion of patent ductus arteriosus in pre-term infants. JACC Cardiovasc Interv 3:550–555PubMedCrossRefGoogle Scholar
  12. 12.
    Ghasemi A, Pandya S, Reddy SV, Turner DR, Du W, Navabi M et al (2010) Trans-catheter closure of patent ductus arteriosus—what is the best device? Catheter Cardiovasc Interv 76:687–695PubMedCrossRefGoogle Scholar
  13. 13.
    Krichenko A, Benson LN, Burrows P, Moes CA, McLaughlin P, Freedom RM (1989) Angiographic classification of the isolated, persistently patent ductus arteriosus and implications for percutaneous catheter occlusion. Am J Cardiol 63:877–880PubMedCrossRefGoogle Scholar
  14. 14.
    Lin CC, Hsieh KS, Huang TC, Weng KP (2009) Closure of large patent ductus arteriosus in infants. Am J Cardiol 103:857–861PubMedCrossRefGoogle Scholar
  15. 15.
    Masura J, Tittel P, Gavora P, Podnar T (2006) Long-term outcome of transcatheter patent ductus arteriosus closure using Amplatzer duct occluders. Am Heart J 151:755.e7–755.e10CrossRefGoogle Scholar
  16. 16.
    Pass RH (2006) Amplatzer duct occluder device: a new technology for the closure of the moderate-to-large-sized patent ductus arteriosus. Expert Rev Med Devices 3:291–296PubMedCrossRefGoogle Scholar
  17. 17.
    Pass RH, Hijazi Z, Hsu DT, Lewis V, Hellenbrand WE (2004) Multicenter USA Amplatzer patent ductus arteriosus occlusion device trial: initial and one-year results. J Am Coll Cardiol 44:513–519PubMedCrossRefGoogle Scholar
  18. 18.
    Rao PS, Sideris EB, Haddad J, Rey C, Hausdorf G, Wilson AD et al (1993) Transcatheter occlusion of patent ductus arteriosus with adjustable buttoned device. Initial clinical experience. Circulation 88:1119–1126PubMedCrossRefGoogle Scholar
  19. 19.
    Thanopoulos B, Eleftherakis N, Tzannos K, Stefanadis C (2008) Transcatheter closure of the patent ductus arteriosus using the new Amplatzer duct occluder: initial clinical applications in children. Am Heart J 156:917.e1–917.e6CrossRefGoogle Scholar
  20. 20.
    Tomita H, Uemura S, Haneda N, Soga T, Matsuoka T, Nishioka T et al (2009) Coil occlusion of PDA in patients younger than 1 year: risk factors for adverse events. J Cardiol 53:208–213PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Osman Baspinar
    • 1
    Email author
  • Ahmet Irdem
    • 1
  • Ercan Sivasli
    • 2
  • Derya Aydin Sahin
    • 2
  • Metin Kilinc
    • 1
  1. 1.Pediatric Cardiology DepartmentGaziantep University Medical FacultyGaziantepTurkey
  2. 2.Neonatology DepartmentGaziantep University Medical FacultyGaziantepTurkey

Personalised recommendations